IE00BQQP9H09
IE00BQQP9H09
VanEck Morningstar US ESG Wide Moat UCITS ETF
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
22.82
Weighted Fwd P/E
15.93
Avg P/FCF
24.47
Avg FCF Yield
3.48%
Avg EV / EBITDA
19.51
Avg EV / Revenue
5.79
Avg Price-to-Book (P/B)
11.91
Avg Price-to-Sales (P/S)
5.53
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-30.2%
Avg Debt-to-Equity (D/E)
142.87%
<50% (30.3%) 50-150% (42.06%) >150% (19.41%) Unreported (8.23%)
Profitability Analysis
57 Holdings CountProfitable 100%
Profitable 100%
57
Holdings Count (100%)
Unprofitable 0%
0
Holdings Count (0%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
15.2%
Top 10
28.5%
Top 25
60.1%
50% Threshold
Top 20
The top 10 make up only 28.5%. Very balanced distribution with minimal single-stock risk. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
4 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (24.0%+)
High (62.3%+)
Top (86.3%+)
Country Breakdown
Max: 95.86%95.86%
1.44%
1.32%
1.24%
Sector Distribution
8 SectorTechnology
27.99%
Healthcare
20.47%
Consumer Defensive
16.52%
Financial Services
10.21%
Industrials
9.20%
Consumer Cyclical
7.51%
Communication Services
6.44%
Basic Materials
1.52%
Industry Distribution
33 IndustriesSoftware - Application
9.76%
Capital Markets
6.71%
Software - Infrastructure
6.44%
Diagnostics & Research
5.73%
Household & Personal Products
5.73%
Semiconductors
5.24%
Drug Manufacturers - General
4.78%
Medical Devices
4.59%
Other
50.88%
Market Cap Distribution
57 Holdings CountMega Cap (> 200B)
(8) 15.11%
Large Cap (10B - 200B)
(42) 72.46%
Mid Cap (2B - 10B)
(7) 12.29%